Swiss All Share Index

Swiss All Share Index handeln
18.178,13 PKT +473,41 PKT +2,67 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
18.04.12 Swiss Re buy Sarasin Research
17.04.12 Sulzer buy Sarasin Research
17.04.12 Sika neutral Sarasin Research
17.04.12 Kühne + Nagel International neutral Sarasin Research
16.04.12 Holcim hold Société Générale Group S.A. (SG)
13.04.12 EMS-CHEMIE buy Sarasin Research
12.04.12 UBS underperform Exane-BNP Paribas SA
12.04.12 Holcim outperform Cheuvreux SA
12.04.12 ABB (Asea Brown Boveri) outperform Exane-BNP Paribas SA
12.04.12 Holcim underperform Cheuvreux SA
12.04.12 Swatch (I) buy Sarasin Research
11.04.12 Givaudan sell Deutsche Bank AG
11.04.12 Novartis buy UBS AG
11.04.12 Givaudan neutral Sarasin Research
10.04.12 Clariant hold Deutsche Bank AG
10.04.12 Novartis neutral J.P. Morgan Cazenove
10.04.12 UBS underperform Cheuvreux SA
10.04.12 Sonova kaufen Die Actien-Börse
05.04.12 Holcim sell Citigroup Corp.
05.04.12 Nestlé overweight HSBC
04.04.12 Barry Callebaut sell Société Générale Group S.A. (SG)
04.04.12 UBS neutral Credit Suisse Group
03.04.12 Nestlé kaufen Norddeutsche Landesbank (Nord/LB)
03.04.12 Givaudan neutral Nomura
03.04.12 Clariant neutral Nomura
03.04.12 Zurich Insurance neutral Sarasin Research
03.04.12 Lonza neutral Sarasin Research
03.04.12 Novartis neutral J.P. Morgan Cazenove
03.04.12 Julius Bär equal-weight Morgan Stanley
03.04.12 UBS buy Goldman Sachs Group Inc.
02.04.12 UBS neutral Nomura
02.04.12 UBS buy Nomura
02.04.12 Novartis buy Sarasin Research
02.04.12 Barry Callebaut neutral Sarasin Research
30.03.12 UBS underperform Exane-BNP Paribas SA
30.03.12 UBS underperform Exane-BNP Paribas SA
30.03.12 Holcim neutral HSBC
30.03.12 Holcim outperform Exane-BNP Paribas SA
30.03.12 Barry Callebaut sell Société Générale Group S.A. (SG)
29.03.12 Zurich Insurance neutral Sarasin Research